1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On February 18, 2025, L3Harris entered a new $2.5 billion, five-year senior unsecured revolving credit facility with JPMorgan Chase Bank as administrative agent, replacing its prior $2 billion facility from July 29, 2022, which the company says incurred no early termination penalties. The company also set up a new $500 million, 364-day revolving facility to replace a $1.5 billion facility that matured on January 24, 2025. The filing describes the terms of these refinancings and does not state any amounts drawn under them, and the excerpt ends partway through Item 2.03.
New $2.5 billion revolver matures February 18, 2030, with a possible one-year extension under certain circumstances.
Prior $2 billion facility dated July 29, 2022 was terminated; the filing says no early termination penalties were incurred.
New $500 million 364-day facility commitments run through February 17, 2026, replacing a $1.5 billion facility that matured January 24, 2025.
Initial interest margin on the $2.5 billion facility is 1.125% over term SOFR, adjustable based on L3Harris senior debt ratings.
Eastman Chemical issued $250 million of 5.000% notes due August 1, 2029, in a public offering, adding to $500 million of the same notes issued in August 2024. The company expects net proceeds of about $246.2 million for general corporate purposes, including working capital, capital expenditures and debt repayment.
Notes: $250 million principal, 5.000% coupon, maturing August 1, 2029, issued February 21, 2025
Expected net proceeds of approximately $246.2 million after underwriting discounts and offering expenses
Underwriting Agreement dated February 18, 2025, with BofA Securities and J.P. Morgan Securities as representatives
Notes form a single series with the $500 million of 5.000% notes issued August 1, 2024
On February 19, 2025, Molina Healthcare entered a third amendment to its credit agreement with Truist Bank as administrative agent, which amends and restates the prior agreement dated June 8, 2020. The amendment adds a $500 million delayed draw commitment that can be drawn for general corporate purposes if the company meets pro forma financial covenants. For shareholders, this adds committed borrowing capacity, though the filing does not say whether any amount has been drawn.
Third amendment dated February 19, 2025, with Truist Bank as administrative agent; prior agreement dated June 8, 2020
$500 million delayed draw commitment, available until June 19, 2025, with a maturity date of February 19, 2027
Applicable margin of 0.125% for base rate loans and 1.125% for SOFR-based loans; ticking fee of 0.25% per annum on the unused commitment
HCA Inc., a wholly owned subsidiary of HCA Healthcare, completed a public offering of $5.25 billion in senior notes on February 21, 2025, across six tranches maturing between 2028 and 2055. The notes are guaranteed on a senior unsecured basis by HCA Healthcare, and the filing adds $5.25 billion of direct financial obligations to the company's debt.
Six tranches total $5.25 billion: $700 million 5.000% notes due 2028, $300 million floating rate notes due 2028, $750 million 5.250% notes due 2030, $750 million 5.500% notes due 2032, $1.5 billion 5.750% notes due 2035 and $1.25 billion 6.
Interest on the fixed-rate notes is payable semi-annually on March 1 and September 1, starting September 1, 2025
The notes were sold under a shelf registration filed May 1, 2023, with underwriters including BofA Securities, Barclays and J.P. Morgan, under an underwriting agreement dated February 18, 2025
Exelon sold $1.0 billion of senior notes on February 21, 2025, split into $500 million of 5.125% notes due 2031 and $500 million of 5.875% notes due 2055. Part of the proceeds, with available cash, will repay $464 million of commercial paper borrowings that carried a weighted average rate of 4.537% as of February 11, 2025, and the rest will fund general corporate purposes. The filing describes a financing transaction that adds long-term debt rather than a change to operations or earnings.
Notes: $500 million of 5.125% due March 15, 2031 and $500 million of 5.875% due March 15, 2055
Interest paid semi-annually on March 15 and September 15, starting September 15, 2025
$464 million of proceeds plus cash on hand to repay commercial paper at about 4.537% weighted average rate
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.